APA (7th ed.) Citation

C, B., A, A., S, E., AR, M., C, M., I, C., . . . M, P. (2019). Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation. BMC cancer, 19(1), 968. https://doi.org/10.1186/s12885-019-6177-0

Chicago Style (17th ed.) Citation

C, Brito, et al. "Clinical Insights Gained by Refining the 2016 WHO Classification of Diffuse Gliomas with: EGFR Amplification, TERT Mutations, PTEN Deletion and MGMT Methylation." BMC Cancer 19, no. 1 (2019): 968. https://doi.org/10.1186/s12885-019-6177-0.

MLA (9th ed.) Citation

C, Brito, et al. "Clinical Insights Gained by Refining the 2016 WHO Classification of Diffuse Gliomas with: EGFR Amplification, TERT Mutations, PTEN Deletion and MGMT Methylation." BMC Cancer, vol. 19, no. 1, 2019, p. 968, https://doi.org/10.1186/s12885-019-6177-0.